Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
The Journal of Hospital Infection|December 3, 1999
The genomic diversity of coagulase-negative staphylococci associated with nosocomial infectionsS Lang, M A Livesley, P A Lambert, et al.
Environmental Toxicology and Pharmacology|February 13, 2001
Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds IIIM D. Coleman, D L. Rathbone, R Chima, et al.
L'Encephale|January 1, 1983
[Effects of gamma-vinyl GABA per os in 5 cases of hebephreno-catatonic schizophrenia]P A Lambert, J P Chabannnes, P Cantiniaux, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
[Neurological complications of tricyclic antidepressive agents]J P Chabannes, P A Lambert, H René-Aussedat, et al.
The Journal of Antimicrobial Chemotherapy|August 16, 2008
Antimicrobial efficacy of chlorhexidine digluconate alone and in combination with eucalyptus oil, tea tree oil and thymol against planktonic and biofilm cultures of Staphylococcus epidermidisT J Karpanen, T Worthington, E R Hendry, et al.
Biochemical Pharmacology|October 17, 1998
Chemical synthesis and biological properties of novel fluorescent antifolates in Pgp- and MRP-overexpressing tumour cell linesC Robson, K A Wright, P R Twentyman, et al.
L'Encephale|July 1, 1985
[Several critical aspects of the value of peripheral markers in depression (TRH test and dexamethasone depression)]J P Chabannes, P A Lambert, H Rene-Aussedat, et al.
FEMS Immunology and Medical Microbiology|November 7, 2000
Identification of a novel antigen from Staphylococcus epidermidisS Lang, M A Livesley, P A Lambert, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1991
Effects of iron depletion and sub-inhibitory concentrations of antibodies on siderophore production by Staphylococcus aureusR J Courcol, P A Lambert, P Fournier, et al.
Environmental Toxicology and Pharmacology|July 26, 2011
Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compoundsM D Coleman, D L Rathbone, L Abberley, et al.
Pageof 14